Resmed Profit Margin

The latest profit margin for RMD is 26.94% as of June 2026. That compares with 27.22% in the prior-year period — down 1.0% year over year. That is above the Healthcare sector average of 21.34%. Investors often review this figure alongside Resmed's historical trend and sector peers before judging valuation or financial health.

Over the past year, RMD's profit margin moved from 27.22% to 26.94% — a 1.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Resmed's valuation or profitability profile.

Against Healthcare companies, RMD currently prints 26.94% for profit margin, while the sector average sits near 21.34%. That is roughly 26.3% above the sector mean. Large gaps often invite a closer look at Resmed's growth, margins, and balance sheet.

Profit Margin shows how effectively Resmed converts resources into returns. At 26.94%, RMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 27.22% in the prior-year period — down 1.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RMD's profit margin (26.94%), review year-over-year change from 27.22%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.